SEB doubled Calliditas PT from SEK125 to SEK230
Calliditas is trading at around 100. SEB increased its price target from 125 to 230 SEK.
SEB summary:
In the wake of the positive confirmatory data for Tarpeyo and positive ph2
interim data for setanaxib, we de-risk our Tarpeyo forecast and add
setanaxib to our SOTP calculation, lifting our estimates and target price to
SEK 230 (125)....
We see limited risk in interim, so we reiterate Buy
SEB summary:
In the wake of the positive confirmatory data for Tarpeyo and positive ph2
interim data for setanaxib, we de-risk our Tarpeyo forecast and add
setanaxib to our SOTP calculation, lifting our estimates and target price to
SEK 230 (125)....
We see limited risk in interim, so we reiterate Buy
DrM
01.08.2023 kl 12:20
270
Spennende case. Hva er saken om at den går for 100 kr på svensk børs, og 20$ over atlanterhavet?
NordicGuy
07.08.2023 kl 11:54
211
Calliditas is reporting on the 17.8. Should be bullish for the stock. At Q1 the company showed high enrollments. These should have been converted into sales in Q2. Bullish